These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 4093243
61. The response to cyclophosphamide in steroid-sensitive nephrotic syndrome is influenced by polymorphic expression of glutathion-S-transferases-M1 and -P1. Vester U, Kranz B, Zimmermann S, Büscher R, Hoyer PF. Pediatr Nephrol; 2005 Apr; 20(4):478-81. PubMed ID: 15717164 [Abstract] [Full Text] [Related]
62. [Cyclophosphamide in idiopathic nephrotic syndrome: Outcome and outlook]. Berkane M, Adarmouch L, Amine M, Bourrahouat A, Ait Sab I, Sbihi M. Nephrol Ther; 2018 Apr; 14(2):85-90. PubMed ID: 29631702 [Abstract] [Full Text] [Related]
63. Long-term, low-dose prednisolone therapy in frequently relapsing nephrotic syndrome. Srivastava RN, Vasudev AS, Bagga A, Sunderam KR. Pediatr Nephrol; 1992 May; 6(3):247-50. PubMed ID: 1616833 [Abstract] [Full Text] [Related]
64. Pattern of response to prednisone in idiopathic, minimal lesion nephrotic syndrome as a criterion in selecting patients for cyclophosphamide therapy. Garin EH, Pryor ND, Fennell RS, Richard GA. J Pediatr; 1978 Feb; 92(2):304-8. PubMed ID: 621614 [Abstract] [Full Text] [Related]
65. Long-term stability of remission in nephrotic syndrome after treatment with cyclophosphamide. Cameron JS, Chantler C, Ogg CS, White RH. Br Med J; 1974 Oct 05; 4(5935):7-11. PubMed ID: 4425844 [Abstract] [Full Text] [Related]
66. Long term follow up of steroid and cyclophosphamide therapy in nephrosis. Ghose S, Kumar M, Kundu B, Bindal S. Indian Pediatr; 1977 Nov 05; 14(11):885-9. PubMed ID: 614301 [No Abstract] [Full Text] [Related]
67. [Value of chlormethine in children with corticoid-dependent or partially corticoid-sensitive nephrosis, in steroid poisoning]. Maisin A, Loirat C, Pillion G, Macher MA, Mathieu H. Arch Fr Pediatr; 1985 Nov 05; 42 Suppl 1():635-8. PubMed ID: 3002292 [Abstract] [Full Text] [Related]
69. [Long-term effects of cyclophosphamide therapy in treatment of the "primary" nephrotic syndrome of childhood]. Lama G. Pediatria (Napoli); 1976 Jun 30; 84(2):320-30. PubMed ID: 798171 [No Abstract] [Full Text] [Related]
70. [Long-term follow-up of the effectiveness of cyclophosphamide in corticodependent and corticoresistant infantile nephrosis. 282 cases treated in an 8-year period]. Forese S, Tamborino G, Genova R. Minerva Pediatr; 1977 Mar 10; 29(8):547-50. PubMed ID: 865435 [No Abstract] [Full Text] [Related]
71. Changes of lymphocyte populations in pediatric steroid-sensitive nephrotic syndrome are more pronounced in remission than in relapse. Kemper MJ, Zepf K, Klaassen I, Link A, Muller-Wiefel DE. Am J Nephrol; 2005 Mar 10; 25(2):132-7. PubMed ID: 15855740 [Abstract] [Full Text] [Related]
72. Alternate-day versus intermittent prednisone in frequently relapsing nephrotic syndrome. A report of "Arbetsgemeinschaft für Pädiatrische Nephrologie". Lancet; 1979 Feb 24; 1(8113):401-3. PubMed ID: 84259 [Abstract] [Full Text] [Related]
73. Cyclophosphamide in steroid-dependent nephrotic syndrome. Azib S, Macher MA, Kwon T, Dechartres A, Alberti C, Loirat C, Deschênes G, Baudouin V. Pediatr Nephrol; 2011 Jun 24; 26(6):927-32. PubMed ID: 21394465 [Abstract] [Full Text] [Related]
74. Adult-onset nephrotic syndrome with minimal changes: response to corticosteroids and cyclophosphamide. Nolasco F, Cameron JS, Hicks J, Ogg CS, Williams DG. Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985 Jun 24; 21():588-93. PubMed ID: 3991549 [Abstract] [Full Text] [Related]
76. An open label non-inferiority randomized controlled trial evaluated alternate day prednisolone given daily during infections vs. levamisole in frequently relapsing nephrotic syndrome. Sinha A, Devi KG, Kalra S, Mani K, Hari P, Bagga A. Kidney Int; 2024 May 24; 105(5):1113-1123. PubMed ID: 38360110 [Abstract] [Full Text] [Related]
77. Comparative study of prednisolone alone and prednisolone plus fusidic acid in the treatment of children with steroid-responsive nephrotic syndrome. Cerkauskiene R, Kaltenis P. Medicina (Kaunas); 2005 May 24; 41 Suppl 1():26-30. PubMed ID: 15901972 [Abstract] [Full Text] [Related]
78. Use of levamisole in maintaining remission in steroid-sensitive nephrotic syndrome in children. Dayal U, Dayal AK, Shastry JC, Raghupathy P. Nephron; 1994 May 24; 66(4):408-12. PubMed ID: 8015643 [Abstract] [Full Text] [Related]
79. Levamisole Therapy as a Second-line Immunosuppressive Agent in Corticosteroid-sensitive Nephrotic Syndrome in Children. Al-Ibrahim AA, Al-Kharraz SM, Al-Sadoon DM, Al-Madani AJ, Al-Musallam SA. Saudi J Kidney Dis Transpl; 2003 May 24; 14(2):153-7. PubMed ID: 18209440 [Abstract] [Full Text] [Related]
80. Steroid-responsive relapsing nephrotic syndrome associated with early diabetic glomerulopathy in a child. Peces R, Riera JR, López Larrea C, Alvarez J. Nephron; 1987 May 24; 46(1):78-82. PubMed ID: 3600916 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]